Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

Dysbiosis of the Gut Microbiota

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Inflammatory Bowel Disease I: Introduction

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...

Microbiota of the Large Intestine

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...

Microbiota of the Stomach and Small Intestine

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Should French pregnant women be vaccinated against pertussis during pregnancy?]

Gynecologie, obstetrique, fertilite & senologie·2022

Same author

Colonization resistance against multi-drug-resistant bacteria: a narrative review.

The Journal of hospital infection·2021

Same author

[Update of Chlamydia trachomatis infection].

Gynecologie, obstetrique, fertilite & senologie·2021

Same author

Spontaneous decolonization during hospitalization in intensive care unit patients colonized by extended-spectrum beta-lactamase-producing Enterobacterales.

The Journal of hospital infection·2020

Same author

Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients.

Journal of Crohn's & colitis·2020

Same author

Towards a European health research and innovation cloud (HRIC).

Genome medicine·2020

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Debugging the intestinal microbiota in IBD.

R Dessein¹, P Rosenstiel, M Chamaillard

¹INSERM U801, Lille, F-59019 France; University of Lille 2, Lille, F-59000, France.

Gastroenterologie Clinique Et Biologique

|February 2, 2010

Summary

This summary is machine-generated.

The human gut microbiota plays a key role in maintaining gastrointestinal health and metabolism. Understanding these microbial communities offers new therapeutic targets for inflammatory bowel diseases.

More Related Videos

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

Published on: June 30, 2021

Related Experiment Videos

Last Updated: Jun 16, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

Published on: June 30, 2021

Area of Science:

Gastroenterology and Immunology
Microbiome Research

Background:

The gastrointestinal tract harbors a complex commensal microbiota.
This microbiota is crucial for tissue homeostasis and metabolism.
Microbial dysbiosis is implicated in inflammatory bowel diseases (IBD).

Purpose of the Study:

To highlight the significance of the human gut microbiota.
To explore its role in gastrointestinal health and disease.
To identify potential therapeutic targets for IBD.

Main Methods:

Literature review on gut microbiota functions.
Analysis of the microbiota's role in homeostasis and metabolism.
Examination of its involvement in inflammatory lesions.

Main Results:

The gut microbiota is essential for maintaining gastrointestinal tissue homeostasis.
It significantly influences host metabolism.
Microbiota alterations are central to the development of inflammatory lesions in IBD.

Conclusions:

A deeper understanding of the human gut microbiota is vital.
Targeting the gut microbiota presents innovative therapeutic strategies for IBD.
Modulating the gut microbiota could lead to cures for gastrointestinal immunopathologies.